Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Apr 12, 2019 (8 years ago)

Alteplase 1 mg/mL 1 mL in 10 mL syringe

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of sterility assurance.

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

Alteplase 1 mg/mL 1 mL in 10 mL syringe, Made by: Enterprise Pharmacy, 4400 Golf Acres Drive, Bldg. J Suite E, Charlotte, NC, 28208.

Drug: Alteplase

Recalling firm
CMC Enterprise Pharmacy
Origin
NC, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1220-2019 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Alteplase recalls

See all
Class II · Moderate risk

Cathflo activase

Lack of Assurance of Sterility: Deformed stoppers observed during filling operations for Cathflo Activase.

Terminated Sterility / contamination Genentech, Inc. NDC 50242-041-64 D-0509-2024
Class II · Moderate risk

cathflo activase

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. NDC 50242-041-64 D-0476-2021
Class II · Moderate risk

Alteplase

Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.

Terminated Sterility / contamination Franck's Lab Inc., d.b.a. Franck's Compounding Lab D-1453-2012

Other recalls by CMC Enterprise Pharmacy

All 2019 recalls